Eradication of Intracellular Salmonella Typhimurium by Polyplexes of Acid‐Transforming Chitosan and Fragment DNA
Open Access
- 18 April 2021
- journal article
- research article
- Published by Wiley in Macromolecular Bioscience
- Vol. 21 (7) , 2000408-e2000408
Abstract
Antibiotics are highly successful against microbial infections. However, current challenges include rising antibiotic resistance rates and limited efficacy against intracellular pathogens. A novel form of a nanomaterial‐based antimicrobial agent is investigated for efficient treatment of an intracellular Salmonella enterica sv Typhimurium infection. A known antimicrobial polysaccharide, chitosan, is engineered to be readily soluble under neutral aqueous conditions for systemic administration. The modified biologic, named acid‐transforming chitosan (ATC), transforms into an insoluble, antimicrobial compound in the mildly acidic intracellular compartment. In cell culture experiments, ATC is confirmed to have antimicrobial activity against intracellular S. Typhimurium in a concentration‐ and pH‐dependent manner, without affecting the host cells, RAW264.7 macrophages. For improved cellular uptake and pharmacokinetic/pharmacodynamic properties, ATC is further complexed with fragment DNA (fDNA), to form nano‐sized spherical polyplexes. The resulting ATC/fDNA polyplexes efficiently eradicated S. Typhimurium from RAW264.7 macrophages. ATC/fDNA polyplexes may bind with microbial wall and membrane components. Consistent with this expectation, transposon insertion sequencing of a complex random mutant S. Typhimurium library incubated with ATC does not reveal specific genomic target regions of the antimicrobial. This study demonstrates the utility of a molecularly engineered nanomaterial as an efficient and safe antimicrobial agent, particularly against an intracellular pathogen.Keywords
Funding Information
- National Institute of Food and Agriculture (2017‐67017‐26180)
- U.S. Department of Agriculture
- National Institutes of Health (R03 AI139557)
- California Institute of Regenerative Medicine (TG2‐01152)
This publication has 36 references indexed in Scilit:
- Antimicrobial and Anti-Inflammatory Activity of Chitosan–Alginate Nanoparticles: A Targeted Therapy for Cutaneous PathogensJournal of Investigative Dermatology, 2013
- “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant eraJournal of Controlled Release, 2011
- Infectious disease: Connecting innate immunity to biocidal polymersMaterials Science and Engineering: R: Reports, 2007
- Effect of chitosan molecular weight and deacetylation degree on hemostasisJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2007
- Bacterial Adhesion and Entry into Host CellsCell, 2006
- Chitosan kills bacteria through cell membrane damageInternational Journal of Food Microbiology, 2004
- Bacterial Invasion: The Paradigms of Enteroinvasive PathogensScience, 2004
- Study on antimicrobial activity of chitosan with different molecular weightsCarbohydrate Polymers, 2003
- intracellular proliferation: where, when and how?Microbes and Infection, 2001
- Immunity to Intracellular BacteriaAnnual Review of Immunology, 1993